Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Business Type Exporter, Manufacturer, Supplier, Trading Company Employee Count 5 Establishment 2025 Working Days To GST NO 27AAKCN5791J1ZS Payment Mode Online Payments (NEFT/RTGS/IMPS), Cheque/DD Related Products Explore Related Categories More Products From This Seller Seller Details GST - 27AAKCN5791J1ZS Trusted Seller Nagpur, Maharashtra Manager Mr Devansh Agrawal Members since 1 Years Address Block No-W/39, Transport Nagar, Nagpur, Maharashtra, 440008, India Report incorrect details
Important Caveats About the Research Several important limitations should be acknowledged when reviewing the EpitalON literature: The majority of published studies originate from Khavinson's research group or closely affiliated laboratories Independent replication outside Russia has been limited, though the 2025 Biogerontology study represents a notable exception Human clinical data remains sparse, consisting mainly of small studies from one research group Most research has used injectable EpitalON, not oral formulations The peptide is not approved as a medicine in the UK, EU, or US How EpitalON Capsules Are Typically Taken Research Protocol Context The research literature commonly references cycles of 10-20 days at 5-10mg daily, repeated periodically (such as once or twice yearly)
Amount per injection: 100 mcg 3 units (0.03 mL) on a U-100 syringe How often: Once a day, under the skin (3060 min before bed, fasted) Length: 812 weeks, then 24 weeks off Start at the lowest useful dose and adjust to the response seen
What it means for you: Offering this as a standard post-procedure add-on differentiates your aftercare protocol and gives clients a reason to book their next procedure with you specifically, knowing recovery will be better managed
Targeted Fat Reduction: The treatment can be precisely targeted to specific areas of the body, allowing for accurate contouring and shaping of the desired area
This copper peptide gene regulation manifests in several clinically significant ways: Downregulation of Pro-Inflammatory Genes: It actively suppresses genes associated with inflammation, such as those in the IL-6 and NF-B pathways, which are major drivers of cellular aging
